COVID-19 Testing
11
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
COVID-19 Antibody and Reinfection Study
Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers
Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers
Optimization of a New Adaptive Intervention to Increase COVID-19 Testing
Rapid Screening for Olfactory Disorders in Covid-19 Infection
Study Utilizing BIOZEK COVID-19 Antigen Rapid Test
Determination of COVID-19 Related Virus in Central Nervous System
Tailored COVID-19 Testing Support Plan for Francophone African Born Immigrants
A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination
Generic Testing of Antigen Tests for COVID-19 in Denmark
Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits